In a press release, Aurora credited Whistler Medical with developing “one of Canada’s most iconic cannabis brands, built on quality, award-winning, organic certified B.C. bud.”
For Aurora, it is pleased to be adding “a premium and differentiated organic certified product suite” to its collection of offerings, and “expanding both its medical and consumer offerings.”
Whistler Medical was founded in 2013 and is one of Canada’s original 10 licensed producers of cannabis. It was also the first licensed producer to receive organic certification and sell organic certified products.
Whistler Medical has a pair of B.C.-based indoor production facilities and expect to produce more than 5,000 kg of cannabis per year in the immediate future. Further down the road, expansion at the company’s Pemberton production facility could lead to 15,000 kg of cannabis being produced annually.
“Now that this transaction is complete, we intend to accelerate development of Whistler and leverage its iconic brand globally,” said Terry Booth, CEO of Aurora. “Applying certain of our best practices to the Whistler cultivation protocols, we anticipate an increase in capacity of the Pemberton facility beyond the stated 5,000 kg annual production target. Furthermore, in pursuing EU GMP certification, we expect, once certified, to offer Whistler’s premium organic flower and derivative products in the much higher margin EU medical cannabis market, further increasing the accretive nature of this transaction. Whistler and Aurora are very much aligned with respect to cannabis culture and community. We expect a swift and successful integration with Whistler, our latest partner.”
Christopher Pelz, CEO and Founder of Whistler, added, “Aurora represents an ideal partner for Whistler, enabling us to maintain our unique craft identity while leveraging the vast resources of Aurora’s large international footprint to rapidly scale our growth and margin profile. We look forward to integrating with the impressive organization that Aurora has developed to continue to produce the highest quality, organic certified cannabis for our medical and consumer markets.”